Nuclear Regulatory Commission December 5, 2008 – Federal Register Recent Federal Regulation Documents

The U. S. Nuclear Regulatory Commission (NRC) has prepared a model license amendment request (LAR), model safety evaluation (SE), and model no significant hazards consideration (NSHC) determination. These are related to changes to standard technical specifications (STS) for Technical Specification Task Force (TSTF)425, Rev. 2, ``Relocate Surveillance Frequencies to Licensee ControlRITSTF Initiative 5b,'' (Agencywide Documents Access Management System (ADAMS) Accession No. ML080280275). The purpose of these models is to permit the NRC to efficiently process amendments that propose to relocate TS surveillance frequencies. Licensees of nuclear power reactors could then request amendments, confirming the applicability of the safety evaluation and NSHC determination to their reactors. The NRC staff is requesting comment on the model safety evaluation and model NSHC determination prior to announcing their availability for referencing in license amendment applications.

The U.S. Nuclear Regulatory Commission will convene a teleconference meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on December 18, 2008, to discuss infiltrations of fluorine-18 and therapeutic radiopharmaceuticals as medical events; and the training and experience requirements for the medical use of NeoVista, Inc.'s Epi-Rad90 strontium-90 ophthalmic system. A copy of the agenda for the meeting will be available at https:// www.nrc.gov/reading-rm/doc-collections/acmui/agenda or by contacting Ms. Ashley Tull using the information below.